- ￥1990
- TargetMol
- 美国
- T39591
- 2025年07月11日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
Human PD-L1 inhibitor I
- 库存：
10
- 供应商：
TargetMol
- CAS号：
2135542-86-6
- 规格：
5 mg
Product Introduction
Bioactivity
英文名:Human PD-L1 inhibitor I
描述:Human PD-L1 inhibitor I is a peptide ligand that specifically inhibits the interaction between human PD-L1 and human PD-1. It exhibits a KD value of 3.39 μM, indicating its binding affinity. The presence of Human PD-L1 inhibitor I disrupts the binding between human PD-L1 and human PD-1, thereby attenuating their respective functions.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Expanding Human T Regulatory Cells with the mTOR-Inhibitor Rapamycin
increasing momentum. However, given the limited amount of circulating FOXP3+ Treg cells, efficient methods for their ex vivo expansion are highly desirable. Rapamycin allows for in vitro expansion of murine and human FOXP3+ Treg cells, which maintain
-amylases of diverse origin. Three major groups of α-amylase have been characterized, based on molecular weight: 60,000, 24,000, and 12,500 Da. The inhibitor forms a complex with amylase. The complex formation can inactivate the amylase and in turn cause
Laboratory Methods for the Assay of Tissue Factor Pathway Inhibitor in Human Plasma
Tissue factor pathway inhibitor (TFPI) is being assayed with increasing frequency by researchers attempting to further understand the complexities of the coagulation system. There are a number of methods available for measurement of TFPI
技术资料暂无技术资料 索取技术资料
